Bring in show music, please. >> Hi, I'm CNBC producer Katie Kramer. Today on Squawk Pod, the promise of a personalized cancer vaccine.We have the CEO of Madna, Stefan Bonscel. >> It's a big moment for medicine, big moment for patients. >> Milestone experimental results that could extend life for patients with the deadly diagnosis of melanoma.MK's Dr. . Dean Lee. We don't know if this is going to be 7 years, 9 years, but there's a chance that you have an increased ability to be disease-free and for a potenti ...

If you could train your immune cells to be like hunting dogs, chasing the tumor, then you could unleash them. But not only could you unleash them, if you could entrain them to smell out that prey, that would be something. And so, in the last 10 years, that's what this result does.What Keytruda does is it's a key. It's a Keytruda. It unlocks the key to let the hound dogs out. Let the dogs out.But what's critical about the technology that Moderna has created is it's a personalized cancer treatment that allows ...

Now to a potential breakthrough in the fight against skin cancer. Merck and Moderna said their personalized cancer vaccines helped cut the reoccurrence of melanoma in a late in a large late stage trial. Bloomberg's Madison Muller covers the sector and joins us.I don't know where to start, Madison, whether it's the breakthrough or just the huge move in Moderna shares this morning. This is a really big reaction to the study. Totally.I mean, there are we're winning sort of on multiple fronts here, and I think ...

Shares of Madna and Merc are surging this morning and that is uh no exaggeration. Check it out. Shares of Merc right now up by about seven and three/4ers percent.Of course, before those moves, this was a company with a $333 billion market cap. So that is substantial when you're talking numbers. And then check out shares of Madna.They are up 63%, a gain of close to $40 right now. Uh the stock is now trading at $102. By the way, before that move, that was a stock with about a $25 billion valuation.So you're p ...